Hospira is voluntarily expanding its recall of its Propofol Injectable Emulsion 1% and Liposyn products, including Liposyn II 10%, Liposyn II 20%, Liposyn III 10%, Liposyn III 20% and Liposyn III 30%, due to particulate matter found in some of the containers, according to an alert from the U.S. Food and Drug Administration.
The affected lot numbers are:
The affected lots of propofol were distributed between March 2008 and April 2010. The affected lots of Liposyn were distributed between Dec. 2008 and April 2010.
Read the FDA’s alert about the Hospira recall.
Health systems across the U.S. are implementing various strategies to manage pharmaceutical expenses while maintaining high care standards. Below are…
U.S. manufacturers of personal protective equipment are struggling to meet growing demand, hindered by high tariffs on Chinese imports, The…
Gaithersburg, Md.-based Adventist HealthCare has named Allison Dichoso vice president and chief human resources officer, effective May 5. Ms. Dichoso…
Comments are closed.
